https://adisinsight.springer.com/drugsafety/803926628?error=cookies_not_supported&code=c76218bc-5cce-4210-b427-254b078053cb
Fhnd 9041 - AdisInsight
Seven patients with stage IV non-small cell lung cancer (NSCLC) harbouring the EGFR p.L747P mutation experienced rapid disease progression despite treatment
adisinsight